PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34546411-3	2021	We herein present the case of an 11-year-old boy previously diagnosed with an ACTA2 gene mutation who developed repetitive transient ischemic attacks and treated with bosentan, an oral endothelin receptor antagonist.	Bosentan	167-175	actin alpha 2, smooth muscle	Homo sapiens	78-83	
34546411-9	2021	Bosentan might be beneficial for treating cerebral ischemia associated with ACTA2 cerebral arteriopathy by maintaining the dilatation of stenotic vessels and adequate systemic blood flow and should be considered before performing revascularization surgery.	Bosentan	0-8	actin alpha 2, smooth muscle	Homo sapiens	76-81